Sana Kliniken AG

Hospital


Location: Ismaning (head quarters), Germany (DE) DE

ISNI: 000000405583380


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Avoidance of Overtreatment of Rectal Cancer by Selective Chemoradiotherapy: Results of the Optimized Surgery and MRI-Based Multimodal Therapy Trial (2020) Ruppert R, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, Sauer J, et al. Journal article Minimal-invasive Stabilisierung bei thorakolumbalen osteoporotischen Frakturen (2020) Schnake KJ, Scheyerer MJ, Spiegl UJA, Perl M, Ullrich BW, Grüninger S, Osterhoff G, et al. Journal article, Review article Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo (2020) Karn T, Denkert C, Weber KE, Holtrich U, Hanusch C, Sinn BV, Higgs BW, et al. Journal article Identification of loci of functional relevance to Barrett's esophagus and esophageal adenocarcinoma: Cross-referencing of expression quantitative trait loci data from disease-relevant tissues with genetic association data (2019) Schröder J, Schüller V, May A, Gerges C, Anders M, Becker J, Hess T, et al. Journal article No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study (2019) Dong J, Gharahkhani P, Chow WH, Gammon MD, Liu G, Caldas C, Wu AH, et al. Journal article Utility of the CPS plus EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy (2019) Marme F, Solbach C, Michel L, Fasching P, Schneeweiss A, Blohmer JU, Rezai M, et al. Conference contribution Ecological validity of the two minute walk test in persons with multiple sclerosis (2019) Weiß V, Hartung V, Tallner A, Streber R, Wanner P, Shammas L, Rashid A, et al. Conference contribution Nab-paclitaxel improves disease-free survival in early breast cancer: GBG 69–Geparsepto (2019) Untch M, Jackisch C, Schneeweiss A, Schmatloch S, Aktas B, Denkert C, Schem C, et al. Journal article A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: Clinical results and biomarker analysis of GeparNuevo study (2019) Loibl S, Untch M, Burchardi N, Huober J, Sinn BV, Blohmer JU, Grischke EM, et al. Journal article Long-term cosmetic outcome after preoperative radio-/chemotherapy in locally advanced breast cancer patients Langfristiges kosmetisches Ergebnis nach neoadjuvanter Radio‑/Chemotherapie bei lokal fortgeschrittenen Brustkrebspatientinnen (2019) Matuschek C, Nestle-Kraemling C, Haussmann J, Bölke E, Wollandt S, Speer V, Djiepmo Njanang FJ, et al. Journal article